2.4.02: Drug Delivery Issue
Six analysts and top management from twelve sector firms examine the drug delivery sector in this special 75-page Drug Delivery issue from The Wall Street Transcript.

    Online subscribers to the Healthcare sector also get
    Investing in the Pharmaceutical Industry Conference Issue & Outlook for Health Care & Pharmaceuticals Report

  1. Drug Delivery - In an in-depth (9,300 words) Analyst Roundtable, Michael J. Hearle, Senior Vice President at Leerink Swann & Co., Ian Sanderson, Managing Director at Managing Director at SG Cowen Securities Corporation, Jerry L. Treppel, Managing Director at Managing Director at Banc of America Securities and Louis C. Webb, Director of Equity Research at RBC Capital Markets, examine the outlook for the sector including investor concerns, earnings expectations and share specific stock recommendations.
  2. Drug Development & Biotechnology Companies - In an in-depth (4,900 words) Analyst Interview, Ken Trbovick, Vice President in equity research at C.E. Unterbergy, Towbin, examines the outlook for the sector and shares specific stock recommendations.
  3. Specialty Pharma, Generics & Vaccines - In an in-depth (3,200 words) Analyst Interview, Robert Wasserman, Director of Research at Sterling Financial Investment Group, examines the outlook for the sector and shares specific stock recommendations.
  4. CEO interviews (average 2,500 words). Top management of twelve sector firms examine the outlook for their firm and the sector. Firms include:
    Flamel Technologies, Aradigm, AVANT Immunotherapeutics, Biojet Medical Technologies, Dendreon, DURECT, Flemington Pharmaceutical, Geron, NABI, IGA Technologies, Titan Pharmaceuticals, DOR BioPharma
    5. ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us
    For immediate access online - click here to gain a password.
     
    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
          		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 
     

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

     

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.

Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE